Unilever plc vs Health Care Select Sector SPDR Fund — how do they compare? Unilever plc trades at $61.66 (market cap $131.63B), while Health Care Select Sector SPDR Fund trades at $168.24 (market cap $43.48B). The key difference: Unilever plc is far larger — about 3× Health Care Select Sector SPDR Fund's market cap, and Unilever plc pays a 3.43% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Unilever plc for 112 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| UL | XLV | |
|---|---|---|
Market Cap | $131.63B | $43.48B |
Volume | 2,978,741 | 11,121,431 |
Sector | Consumer Staples | — |
52-Week High | $74.59 | $175.68 |
52-Week Low | $55.05 | $141.95 |
Typical Hold Time | 112 Days | 100 Days |
Enterprise Value | $156.65B | — |
Dividend Yield | 3.43% | — |
Signals from Pluang's Aura AI — not financial advice
Unilever (UL) trades at $60.98, up 0.3% on the day, amid a bearish technical outlook and mixed financial performance. Revenue declined to $50.50 billion in 2025, though net income improved to $9.47 billion, with a high net margin of 18.74%. Recent earnings have consistently missed expectations, while the company is streamlining its portfolio through a planned food business merger with McCormick, facing regulatory scrutiny.
The stock presents a cautious outlook with strong profitability metrics like a 54.56% ROE offset by valuation concerns (P/E of 21.59) and earnings misses. Risks include integration challenges from the McCormick deal and competitive pressures, but its focus on beauty and personal care offers growth potential in emerging markets.
XLV trades at $168.81, up 1.03% today, with a bullish technical signal driven by moving averages. The ETF holds 61 healthcare stocks from the S&P 500, offering broad sector exposure at a low 0.08% expense ratio. Recent news highlights its defensive appeal amid market volatility and potential Fed rate hikes, with articles comparing it favorably to peers like IBB and PJP on cost and diversification.
Outlook is positive given healthcare's defensive growth profile and XLV's cost efficiency, but risks include political uncertainty from midterm elections and sector-specific volatility from drug trial outcomes. Wall Street sentiment is constructive, with the ETF near key resistance at $170.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Read more on UL →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →